CAL · Caleres Inc

The thesis

Caleres' brand-led earnings recovery is real, but a shrinking Famous Footwear chain and Q3 guidance below expectations keep the case contested. The Q3 report, expected in early December, settles whether the raised $1.50–$1.65 fiscal 2026 adjusted earnings per share (EPS) range holds.

The 9 September 2026 Q2 report beat on adjusted EPS, $0.47 against $0.37 expected, per earnings coverage that day. Q3 guidance of $0.62–$0.70 came in below the $0.83 expected. The narrative is maturing: the Q2 report and the tariff-refund recognition are well known, and no company-dated event sits inside the next 30 days.

The shares closed at $12.96 on 28 October 2026 (adjusted daily closes), down from $13.14 on 15 October 2026 and 11.5% below the $14.64 adjusted 52-week high. The three-month change is +1.6% and the 14-day relative strength index (RSI) is 57.6. Searches on 29 October 2026 found no company news, filing or analyst revision dated after the Q2 report, so the business facts behind the rating are unchanged. The mid-October rise has partly reversed without a new fact behind it.

Bullish and bearish views on Caleres Inc

The bull case on Caleres Inc (CAL), in brief: Brand Portfolio growth is broad. The bear case: Famous Footwear still shrinks.

Bull case

• Brand Portfolio growth is broad. Q2 Brand Portfolio sales rose 23.6%, including 8.2% organic growth, per the company's 9 September 2026 release. The organic figure strips out the Stuart Weitzman acquisition.
• The earnings floor moved up. Fiscal 2026 adjusted EPS guidance rose to $1.50–$1.65 from $1.40–$1.65 on 9 September 2026; the ceiling did not change.
• Famous Footwear steadied after quarter-end. Chief Financial Officer Daniel Karpel said comparable sales were flat quarter-to-date through Labor Day on the 9 September 2026 call.
• Refund recognised, earnings modest against the price. Q2 results included $57.4M of tariff refunds and interest, excluded from adjusted earnings (9 September 2026 call). Trailing twelve-month EPS was $1.54 on 2 October 2026, per stockanalysis.com.

Bear case

• Famous Footwear still shrinks. Q2 comparable sales fell 5.9% and segment sales fell 6.3% (company release, 9 September 2026). Consolidated sales excluding Stuart Weitzman fell 0.8%.
• Q3 guidance trails expectations. Adjusted EPS of $0.62–$0.70 compares with $0.83 expected (earnings coverage, 9 September 2026). The company expects Q3 gross margin to expand 1.5 to 2.0 percentage points on tariff mitigation and lower current tariff rates.
• Promotions and tariffs weigh on margin. Karpel said Famous Footwear promotions would continue, and guidance assumes replacement tariffs in Q3 (9 September 2026 call).
• Channel peers are weak. JD Sports reported North America like-for-like sales down 6.8% on 20 August 2026, and Caleres shares fell 7.2% in the morning session that day (StockStory).

Price setup

The adjusted close was $12.96 on 28 October 2026, against $13.14 on 15 October 2026, $12.22 on 2 October 2026 and $11.74 on 18 September 2026. The 24 July 2026 close of $11.78 and the 18 September 2026 close of $11.74 are the lows the shares have held since the summer. The $11.70 weekly-close level sits under both and below the current price.

The shares remain below the $14.64 adjusted 52-week high. The RSI of 57.6 compares with 63.2 on 15 October 2026 and 44.9 on 2 October 2026, so momentum has cooled from mid-October and remains above its early-October reading. The consensus target is $17.00 from two analysts (stockanalysis.com and Bullstory, 2 October 2026), with individual targets ranging from $16 to $18. MarketBeat's page, refreshed around 31 July 2026, shows a "Reduce" consensus rating from three analysts. The annual dividend is $0.28.

Crowding evidence is light. Coverage is two analysts with targets, no earnings report falls inside 30 days, and no Form 4 insider transaction was found. The analyst count is small, so one revision moves the printed consensus sharply.

Catalysts, next 30 days

• ~18 November 2026, est.: Q3 results date notice. In 2025 the company announced its date on 18 November 2025, about three weeks ahead of the report. The notice would fix when the $0.62–$0.70 Q3 guide is tested.
• Rolling: analyst target changes. One revision from either of the two analysts moves the $17.00 consensus.
• ~3 December 2026, est.: Q3 FY2026 report, after the 30-day window. The company has not confirmed the date; Q3 2025 was reported on 9 December 2025. The report tests Q3 guidance, the annual range and the Famous Footwear comparable against -5.9% in Q2.

Elapsed catalysts

• Rolling: tariff refund collection or appeal ruling. The $57.4M refund and interest is booked; cash receipt or a ruling on the government's 2 June 2026 appeal of the Court of International Trade order would confirm or question it. (passed 157d ago)

What would change the view

The case breaks if Famous Footwear Q3 comparable sales come in worse than the -5.9% of Q2, or if the $1.50 floor of fiscal 2026 adjusted EPS guidance is cut. Either result would show the brand growth no longer offsets the retail chain. A Q3 gross margin gain below the 1.5 to 2.0 percentage points guided, or an enacted replacement tariff above the company's assumption, would also weaken it.

On price, a weekly close below $11.70 would sit under both the 24 July 2026 close of $11.78 and the 18 September 2026 close of $11.74. That would end the pattern of higher lows since July.

Upside evidence would be Q3 adjusted EPS at or above the top of the $0.62–$0.70 guide, with Famous Footwear comparable sales better than flat.

What it trades with

Caleres trades with US discretionary retail and footwear names, and with moves in tariff headlines for China and Vietnam sourcing. JD Sports' 20 August 2026 profit warning showed that North American footwear retail weakness can move the shares on the same day (down 7.2% in the morning session, per StockStory). The Brand Portfolio segment is exposed to department-store and online wholesale demand, while Famous Footwear follows value-footwear consumer traffic.